Market›Health Care›Health Care Providers & Services›Health Care Services
NOVO INTEGRATED SCIE

NVOS

$0.00Apr 28, 2021 – Apr 27, 2026
Health CareHealth Care Providers & ServicesHealth Care Services$0M
MVM
-$0.0M
TD Variance
-1300.000

Every news event mapped to its market reaction — 89 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2024-05-31+174.0%newsSeeking AlphaNovo Integrated conducts strategic review to increase amount under buyback program
2025-04-04-75.2%legalSEC EDGARNVOS 8-K: 5.02 (SEC Filing)
2022-10-14-64.9%newsSeeking AlphaNovo Integrated Sciences prices 4M unit public offering at $.50/unit
2022-10-14-64.9%legalSEC EDGARNVOS 8-K: 1.01, 7.01 (SEC Filing)
2025-10-15+60.2%newsSeeking AlphaClearBridge Large Cap Value adds TSM and PNC, exits Novo Nordisk and U.S. Bancorp
2023-11-06-50.2%newsSeeking AlphaNovo Integrated Sciences stock plunges 54% amid stock split, debt update
2023-11-06-50.2%newsSeeking AlphaNovo Integrated Sciences announces reverse stock split
2023-09-18-37.4%legalSEC EDGARNVOS 8-K: 1.01, 2.03, 3.02 (SEC Filing)
2024-07-08-36.3%newsSeeking AlphaNovo Integrated Sciences files to resell 3.5M shares by holders
2024-04-15+35.9%earningsSeeking AlphaNovo Integrated Sciences GAAP EPS of -$0.16, revenue of $3.17M
2024-04-15+35.9%legalSEC EDGARNVOS 8-K: 2.02 and (SEC Filing)
2023-09-08+28.1%newsSeeking AlphaNovo Integrated Sciences considers up to $5M share buyback program
2022-03-24-25.6%newsSeeking AlphaNovo Integrated stock rises 9% on patent for oral pouch delivery system technology
2023-09-28+25.2%expansionSeeking AlphaNovo Integrated Sciences signs $1B master collateral transfer agreement
2023-09-28+25.2%legalSEC EDGARNVOS 8-K: 1.01, 7.01 (SEC Filing)
2023-02-14+22.4%legalSEC EDGARNVOS 8-K: 3.02 and 8.01 (SEC Filing)
2023-01-06+20.6%legalSEC EDGARNVOS 8-K: 1.01 and (SEC Filing)
2022-03-23-18.6%M&ASeeking AlphaNovo Integrated Sciences agrees to acquire Clinical Consultants International LLC in all stock deal
2024-02-16+18.1%legalSEC EDGARNVOS 8-K: 5.02, 7.01 (SEC Filing)
2023-05-24-17.0%earningsSeeking AlphaNovo Integrated Sciences GAAP EPS of -$0.12, revenue of $3.42M
2023-05-24-17.0%legalSEC EDGARNVOS 8-K: 2.02 and (SEC Filing)
2025-03-11-16.6%legalSEC EDGARNVOS 8-K: 5.02 (SEC Filing)
2024-11-20+16.5%legalSEC EDGARNVOS 8-K: 8.01 (SEC Filing)
2023-11-27-15.0%legalSEC EDGARNVOS 8-K: 1.01 and (SEC Filing)
2023-01-26-13.1%legalSEC EDGARNVOS 8-K: 3.02 (SEC Filing)
2023-01-17-12.8%legalSEC EDGARNVOS 8-K: 3.02, 7.01 (SEC Filing)
2022-04-13+12.3%earningsSeeking AlphaNovo Integrated Sciences GAAP EPS of -$0.17, revenue of $2.87M
2022-04-13+12.3%legalSEC EDGARNVOS 8-K: 2.02 and (SEC Filing)
2023-05-25-11.6%legalSEC EDGARNVOS 8-K: 8.01 (SEC Filing)
2024-03-19-11.4%legalSEC EDGARNVOS 8-K: 1.01 and (SEC Filing)
2022-12-21-10.5%newsSeeking AlphaNovo Integrated Sciences receives non-compliance notice from Nasdaq
2024-04-11-10.4%legalSEC EDGARNVOS 8-K: 1.01, 2.03, 3.02, 7.01 (SEC Filing)
2023-04-03-10.2%earningsSeeking AlphaNovo Integrated Sciences GAAP EPS of -$1.13, revenue of $11.74M
2023-04-03-10.2%legalSEC EDGARNVOS 8-K: 2.02 and (SEC Filing)
2023-05-26-10.2%legalSEC EDGARNVOS 8-K: 2.02 and (SEC Filing)
2023-07-17-9.9%earningsSeeking AlphaNovo Integrated Sciences GAAP EPS of -$0.01, revenue of $3.29M
2023-07-17-9.9%legalSEC EDGARNVOS 8-K: 2.02 and (SEC Filing)
2023-03-27-9.2%legalSEC EDGARNVOS 8-K: 1.01, 2.03, 3.02 (SEC Filing)
2023-09-27-9.2%legalSEC EDGARNVOS 8-K: 5.03, 8.01 (SEC Filing)
2022-08-04+8.8%legalSEC EDGARNVOS 8-K: 8.01 (SEC Filing)
2023-09-13+8.4%newsSeeking AlphaNovo Integrated Sciences stock continues to climb amid buyback news
2022-12-30-8.0%legalSEC EDGARNVOS 8-K: 1.01 and (SEC Filing)
2023-06-26-7.5%legalSEC EDGARNVOS 8-K: 1.01, 2.03, 3.02 (SEC Filing)
2022-07-11+7.3%earningsSeeking AlphaNovo Integrated Sciences expects to report over fivefold increase in Q3 revenue
2022-07-11+7.3%legalSEC EDGARNVOS 8-K: 2.02 and (SEC Filing)
2024-07-19+7.2%legalSEC EDGARNVOS 8-K: 2.02 and (SEC Filing)
2022-04-07-7.1%legalSEC EDGARNVOS 8-K: 5.02, 7.01, 8.01 (SEC Filing)
2024-02-20+6.9%legalSEC EDGARNVOS 8-K: 1.01, 7.01 (SEC Filing)
2022-11-15-6.7%legalSEC EDGARNVOS 8-K: 1.01 and (SEC Filing)
2022-10-18+6.3%legalSEC EDGARNVOS 8-K: 1.01 and (SEC Filing)
2023-04-27+6.2%newsSeeking AlphaNovo Integrated Sciences up 16% on issuance of $70M note
2023-04-27+6.2%legalSEC EDGARNVOS 8-K: 1.01, 2.03, 7.01 (SEC Filing)
2024-03-18-6.2%legalSEC EDGARNVOS 8-K: 1.01 and (SEC Filing)
2024-06-03+5.5%legalSEC EDGARNVOS 8-K: 1.01, 7.01 (SEC Filing)
2024-04-10-5.4%legalSEC EDGARNVOS 8-K: 3.02 (SEC Filing)
2024-10-31-5.3%legalSEC EDGARNVOS 8-K: 5.02 (SEC Filing)
2022-07-14+5.3%legalSEC EDGARNVOS 8-K: 2.02 and (SEC Filing)
2024-01-22+5.1%earningsSeeking AlphaNovo Integrated Sciences GAAP EPS of -$0.28, revenue of $3.89M
2024-01-22+5.1%legalSEC EDGARNVOS 8-K: 2.02 and (SEC Filing)
2023-06-02-5.0%legalSEC EDGARNVOS 8-K: 5.02, 8.01 (SEC Filing)
2023-03-01+5.0%legalSEC EDGARNVOS 8-K: 1.01, 2.03, 3.02 (SEC Filing)
2022-04-26+4.9%executivePRUndergroundNovo Integrated Sciences’ Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year - PRUnderground
2024-12-18+4.6%earningsSeeking AlphaNovo Integrated Sciences GAAP EPS of -$0.89, revenue of $13.29M
2024-12-18+4.6%legalSEC EDGARNVOS 8-K: 2.02 and (SEC Filing)
2024-06-27-4.4%newsSeeking AlphaNovo Integrated Sciences: A Coil Spring Ready To Explode
2024-06-27-4.4%legalSEC EDGARNVOS 8-K: 1.01 and (SEC Filing)
2022-01-18+4.3%earningsSeeking AlphaNovo Integrated Sciences GAAP EPS of -$0.07, revenue of $3.16M
2023-11-24+3.7%newsSeeking AlphaNovo Integrated Sciences regains compliance with Nasdaq minimum bid price requirement
2023-11-24+3.7%legalSEC EDGARNVOS 8-K: 7.01, 8.01 (SEC Filing)
2023-08-30+3.7%legalSEC EDGARNVOS 8-K: 2.04, 3.02 (SEC Filing)
2023-09-22-3.4%legalSEC EDGARNVOS 8-K: 1.01, 2.03 (SEC Filing)
2023-07-03-3.2%legalSEC EDGARNVOS 8-K: 5.02 and (SEC Filing)
2024-07-22+2.8%earningsSeeking AlphaNovo Integrated Sciences GAAP EPS of -$0.74, revenue of $3.15M
2025-02-11-2.7%legalSEC EDGARNVOS 8-K: 5.02 (SEC Filing)
2023-10-24+2.4%newsSeeking AlphaNovo Integrated Sciences' broad approves $5M stock repurchase program
2023-12-14-2.3%earningsSeeking AlphaNovo Integrated Sciences GAAP EPS of -$1.30, revenue of $12.57M
2023-12-14-2.3%legalSEC EDGARNVOS 8-K: 2.02 and (SEC Filing)
2024-06-25+2.1%legalSEC EDGARNVOS 8-K: 5.02 and (SEC Filing)
2024-11-14+1.9%legalSEC EDGARNVOS 8-K: 5.02 and 8.01 (SEC Filing)
2022-07-15-1.1%earningsSeeking AlphaNovo Integrated Sciences GAAP EPS of -$0.13, revenue of $13.85M
2023-07-12-0.9%legalSEC EDGARNVOS 8-K: 5.02 (SEC Filing)
2024-07-07-0.8%earningsSeeking AlphaEarnings week ahead: PepsiCo, Delta Air Lines, JPMorgan, Citigroup and more
2023-03-24+0.7%legalSEC EDGARNVOS 8-K: 8.01 and (SEC Filing)
2023-01-30+0.4%newsSeeking AlphaNovo Integrated Sciences receives non-compliance notice from Nasdaq
2023-01-30+0.4%legalSEC EDGARNVOS 8-K: 3.01, 3.02, 7.01 (SEC Filing)
2025-05-06+0.4%legalSEC EDGARNVOS 8-K: 5.02 (SEC Filing)
2025-05-06+0.4%executiveTipRanksNovo Integrated Sciences CEO Transition by May 31, 2025 - TipRanks
2022-07-07+0.2%legalSEC EDGARNVOS 8-K: 5.02 and 8.01 (SEC Filing)
2025-02-25+0.1%legalSEC EDGARNVOS 8-K: 5.02 (SEC Filing)
tickerdossier.comtickerdossier.substack.com